Home

Ingmar Bruns, Chief Medical Officer: Zentalis Pharmaceuticals ZNTL Sell · Filed 02/10

Trade details

Type
Insider sale
Amount
$800.65
Shares · price
335 sh · $2.39 a share
Held after
33,332 sh
Trade date
26/02/09
Filed
26/02/10
Days to filing
1 days

Sold 1.0% of holdings

Share of holding sold
1.0%

Zentalis Pharmaceuticals trades, last 26 weeks

What else happened in Zentalis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/10~03/11

Ingmar Bruns's recent trades

  • Ingmar Bruns

    SellZentalis Pharmaceuticals

    $7,198

    Filed 02/10

  • Ingmar Bruns

    BuyZentalis Pharmaceuticals

    $45.6K

    Filed 25/02/12